CD19 and acute lymphoblastic leukemia: In a pilot clinical trial led by the Children's Hospital of Philadelphia (CHOP) and the University of Pennsylvania and published in 2014, 25 children and 5 young adults with r/r B-ALL were treated with CD19 CAR (1).